These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8797563)

  • 1. Growth inhibition of squamous cell carcinoma xenografts with the polyamine analogue BE 4444.
    Auchter RM; Pickart MA; Nash GA; Qu RP; Harari PM
    Arch Otolaryngol Head Neck Surg; 1996 Sep; 122(9):977-81. PubMed ID: 8797563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slowing proliferation in head and neck tumors: in vitro growth inhibitory effects of the polyamine analog BE-4-4-4-4 in human squamous cell carcinomas.
    Harari PM; Pickart MA; Contreras L; Petereit DG; Basu HS; Marton LJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):687-94. PubMed ID: 7790255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
    Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
    Porter CW; Bernacki RJ; Miller J; Bergeron RJ
    Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the polyamine analogues BE-4-4-4-4, BE-3-7-3, and BE-3-3-3 on the proliferation of three prostate cancer cell lines.
    Jeffers L; Church D; Basu H; Marton L; Wilding G
    Cancer Chemother Pharmacol; 1997; 40(2):172-9. PubMed ID: 9182840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15- triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines.
    Basu HS; Pellarin M; Feuerstein BG; Shirahata A; Samejima K; Deen DF; Marton LJ
    Cancer Res; 1993 Sep; 53(17):3948-55. PubMed ID: 8358722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor.
    Burns MR; Graminski GF; Weeks RS; Chen Y; O'Brien TG
    J Med Chem; 2009 Apr; 52(7):1983-93. PubMed ID: 19281226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
    Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
    Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
    Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
    Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
    Huang SM; Harari PM
    Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of N1,N4-dibenzylputrescine in human and rodent tumor cells.
    Aizencang G; Harari P; Buldain G; Guerra L; Pickart M; Hernandez P; Frydman B
    Cell Mol Biol (Noisy-le-grand); 1998 Jun; 44(4):615-25. PubMed ID: 9678897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cytotoxic agent for human carcinoid tumors.
    Litvak DA; Papaconstantinou HT; Ko TC; Townsend CM
    Surgery; 1998 Dec; 124(6):1071-6. PubMed ID: 9854585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining polyamine depletion with radiation therapy for rapidly dividing head and neck tumors: strategies for improved locoregional control.
    Petereit DG; Harari PM; Contreras L; Pickart MA; Verma AK; Gerner EW; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):891-8. PubMed ID: 8138442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
    Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
    Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of proliferation kinetics in human squamous cell carcinomas of the head and neck.
    Harari PM; Contreras L; Pickart MA; Ritter MA; Kinsella TJ
    Arch Otolaryngol Head Neck Surg; 1993 Jul; 119(7):738-42. PubMed ID: 8318203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
    Dolan ME; Fleig MJ; Feuerstein BG; Basu HS; Luk GD; Casero RA; Marton LJ
    Cancer Res; 1994 Sep; 54(17):4698-702. PubMed ID: 8062267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
    Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma.
    Prudencio J; Akutsu N; Benlimame N; Wang T; Bastien Y; Lin R; Black MJ; Alaoui-Jamali MA; White JH
    J Natl Cancer Inst; 2001 May; 93(10):745-53. PubMed ID: 11353784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.
    Bernacki RJ; Bergeron RJ; Porter CW
    Cancer Res; 1992 May; 52(9):2424-30. PubMed ID: 1568212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
    Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
    Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.